Mainland China

Keymed Biosciences Announces 2025 Annual Results and Business Updates

BEIJING, March 26, 2026 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. The year marked the company's 10th anniversary and a pivotal year in its transition from R&D to commercialization. Revenue Leaps Forward, Supporting Long-Term Stable Growth Since its found...

2026-03-26 21:54 7189

CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Rapid Advancement Across Core R&D Pipeline * The global, multicenter Phase I/II clinical trial of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) is actively enrolling patients in Australia and China, and the Phase II IND application has been approved in the US. CS2009 demonstrates an excellent...

2026-03-26 21:32 11130

Addentax Group Corp. Announces Reverse Stock Split

SHENZHEN, China, March 26, 2026 /PRNewswire/ -- Addentax Group Corp. (Nasdaq: ATXG) (the "Company") announced today that following the stockholder approval of the reverse stock split proposal at the Company's 2025 Annual Meeting of Stockholders held on January 30, 2026, the Board of Directors of ...

2026-03-26 21:00 6915

C-Ray Therapeutics and SHINE Technologies Enter Strategic Partnership for Exclusive Distribution of No-Carrier-Added Lu-177 in Mainland China

CHENGDU, China and JANESVILLE, Wis., March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of aMaster Radioisotope Supply Agreement with SHINE Technologies, LLC (Janesville, Wisconsin, USA), establishing a long-term, ...

2026-03-26 20:53 4478

CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

Key Highlights: * Excellent Safety Profile:  As of mid-March 2026, 113 heavily pretreated patients with solid tumors have been enrolled in the Phase I trial of CS2009, with a median follow-up of approximately 6 months. The more mature data continue to show a favorable safety profile, with23% i...

2026-03-26 20:53 6891

Tales & Trails | Beijing: Where ancient legacy meets high tech

BEIJING, March 26, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn:   Join China Daily journalist Erik Nilsson on a tour of Beijing to explore its timeless charm alongside a tech-powered future. A stroll around Beijing is a journey through time, where centuries-old...

2026-03-26 20:02 5551

Peijia Medical Announces 2025 Annual Results

SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its annual results for the year ended December 31, 2025 on March 25, 2026. During th...

2026-03-26 20:00 6135

ChinaAMC celebrates the power of AI by launching major events

The pioneer in China's asset management industry traces its long history with AI back to 2017, when it launched a partnership with Microsoft Research Asia BEIJING, March 26, 2026 /PRNewswire/ -- China Asset Management Co.(ChinaAMC) in March concluded a series of high-profile events, showcasing it...

2026-03-26 19:51 6391

Lasermach by Wingderm® Receives FDA Clearance for All Three Wavelengths

BEIJING, March 26, 2026 /PRNewswire/ -- Wingderm®, a manufacturer of medical aesthetic devices, announces that its Lasermach system has received expanded clearance from the U.S. Food and Drug Administration (FDA). With this latest clearance, Lasermach now achieves FDA clearance across all three w...

2026-03-26 18:00 3098

Innovent Announces 2025 Annual Results and Business Updates

From China Leadership to Global Premier: Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization SAN FRANCISCO and SUZHOU, China, March 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develop...

2026-03-26 18:00 7861

Hengrui Pharma Announces Strong 2025 Annual Results

SHANGHAI, March 25, 2026 /PRNewswire/ -- On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13% year-on-year to RMB 31.63 billion, and net profit attribut...

2026-03-26 08:52 4625

X Financial Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

SHENZHEN, China, March 25, 2026 /PRNewswire/ -- X Financial (NYSE: XYF), a leading Chinesefintech platform, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. This press release should be read in conjunction with the Company's Report on...

2026-03-26 04:50 6502

From seeing to clarity: 3 must-buy 70mai Dash Cams this Spring Sale

SHANGHAI, March 25, 2026 /PRNewswire/ -- 70mai, a global smart car electronics company with a specialization in dashboard cameras, today announced the launch of its Spring Sale to help millions of road-trippers stay protected.With discounts of up to 44%, advanced dash cam technology is now availa...

2026-03-25 21:00 3701

Erayak Strategic Roadmap: Providing a High-Precision Energy Defense Against Global Oil and Grid Volatility

Optimizing Tri-Fuel "Infinite Runtime" and Utility-Grade Power Quality to Shield Modern Households from Energy Crises WENZHOU, China, March 25, 2026 /PRNewswire/ -- Erayak Power Solution Group Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a leading developer of ...

2026-03-25 20:05 4920

Cheche Group Schedules Second Half and FY 2025 Earnings Release and Conference Call Date

BEIJING, March 25, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced it will host a conference call to discuss results for the Second Half and Full Year 2025 on T...

2026-03-25 20:00 4773

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics ...

2026-03-25 20:00 5246

Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

BEIJING, March 25, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("Kingsoft Cloud" or the "Company") (NASDAQ: KC and HKEX: 3896), a leading cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Mr. ...

2026-03-25 19:57 4922

Tantech Holdings Ltd Announces Notice of Allowance from U.S. Patent and Trademark Office for Hanging Cabinet Design Patent

LISHUI, China, March 25, 2026 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) (the "Company" or "Tantech"), today announced that its U.S. subsidiary, Tanhome Group Inc., has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) for a Hanging Cabinet d...

2026-03-25 18:30 5424

WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture

SHANGHAI, March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released its annual results for 2025, demonstrating record growth and a transformative leap in operational sophistication. Th...

2026-03-25 18:22 5915

HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering

Listing milestone positions HanchorBio to strengthen institutional visibility, advance itsFBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases TAIPEI, SHANGHAI and SAN FRANCISCO, March 25, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a globa...

2026-03-25 18:00 4679
1 ... 30313233343536 ... 811